ASolution Propofol ASolution Propofol

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for MolPort-001-794-517

    Client Email Product

    MolPort-001-794-517

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    32
    US DMFs Filed

    US DMFs Filed

    12
    CEP/COS Certifications

    CEP/COS Certifications

    10
    JDMFs Filed

    JDMFs Filed

    5
    Other Certificates

    Other Certificates

    3
    Other Suppliers

    Other Suppliers

    21
    API REF. PRICE (USD / KG)
    309

    API Market Place

    17
    INTERMEDIATES
    1
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    13
    Europe

    Europe

    64
    Canada

    Canada

    7
    Australia

    Australia

    0

    South Africa

    South Africa

    22
    Uploaded Dossiers

    Uploaded Dossiers

    30
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    39
    EXCIPIENTS
    11
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    2

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    31
    REF STANDARD

    EDQM

    3

    USP

    5

    JP

    0

    Other Listed Suppliers

    6
    SERVICES

    0

    Full View ScreenFull Screen View
    Enforcement Report - Week of September 21, 2022
    Enforcement Report - Week of September 21, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-21-2022-99399.pdf

    FDA
    21 Sep 2022
    Share Share
    Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable
    Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-issues-voluntary-nationwide-recall-one-lot-propofol-injectable-emulsion-containing-benzyl

    FDA
    22 Aug 2022
    Share Share
    Genixus Introduces Propofol to be Delivered Within KinetiX RTA Syringe Platform
    Genixus Introduces Propofol to be Delivered Within KinetiX RTA Syringe Platform

    https://www.prnewswire.com/news-releases/genixus-introduces-propofol-as-the-first-product-to-be-delivered-within-kinetix-ready-to-administer-rta-syringe-platform-301602678.html

    PRNEWSWIRE
    09 Aug 2022
    Share Share
    Enforcement Report - Week of August 3, 2022
    Enforcement Report - Week of August 3, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-3-2022-1659944441.pdf

    FDA
    03 Aug 2022
    Share Share
    Hospira issues a recall for propofol due to visible particulate
    Hospira issues a recall for propofol due to visible particulate

    https://endpts.com/pfizers-hospira-issues-a-recall-for-a-batch-of-propofol-due-to-a-visible-particulate/

    Tyler Patchen ENDPTS
    16 Jul 2022
    Share Share
    Hospira Issues a Voluntary Nationwide Recall for One Lot of Propofol Injectable Emulsion
    Hospira Issues a Voluntary Nationwide Recall for One Lot of Propofol Injectable Emulsion

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-issues-voluntary-nationwide-recall-one-lot-propofol-injectable-emulsion-usp-containing

    FDA
    14 Jul 2022
    Share Share
    Avet Pharma Announces Approval and Launch of Propofol Injectable Emulsion
    Avet Pharma Announces Approval and Launch of Propofol Injectable Emulsion

    https://www.prnewswire.com/news-releases/avet-pharmaceuticals-announces-approval-and-launch-of-propofol-injectable-emulsion-usp-301519466.html

    PRNEWSWIRE
    07 Apr 2022
    Share Share
    Emcure Pharms` Generic Propofol Receives Approval In US
    Emcure Pharms` Generic Propofol Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206408

    FDA
    15 Oct 2021
    Share Share
    Fine chemicals: Axyntis relocates the production of pharmaceutical active ingredients
    Fine chemicals: Axyntis relocates the production of pharmaceutical active ingredients

    https://www.lesechos.fr/pme-regions/centre-val-de-loire/chimie-fine-axyntis-relocalise-la-production-dactifs-pharmaceutiques-1312444

    Christine Berkovicius LESECHOS
    21 May 2021
    Share Share
    Dexmedetomidine Ties Propofol for Intubated Adults With Sepsis
    Dexmedetomidine Ties Propofol for Intubated Adults With Sepsis

    https://www.medpagetoday.com/meetingcoverage/sccm/91017

    MEDPAGE
    02 Feb 2021
    Share Share
    Diprivan® (Propofol) Injectable Emulsion, USP First Product Available Fresenius
    Diprivan® (Propofol) Injectable Emulsion, USP First Product Available Fresenius

    https://www.businesswire.com/news/home/20201008005150/en

    BUSINESSWIRE
    08 Oct 2020
    Share Share
    Innopharma's Generic Propofol Receives Approval In US
    Innopharma's Generic Propofol Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205576

    FDA
    16 Sep 2020
    Share Share
    Sedative that Received FDA Emergency Use Authorization Now from Fresenius Kabi
    Sedative that Received FDA Emergency Use Authorization Now from Fresenius Kabi

    https://www.businesswire.com/news/home/20200615005199/en

    BUSINESSWIRE
    15 Jun 2020
    Share Share
    Bachem ensures global market supply of the API Propofol from Swiss production
    Bachem ensures global market supply of the API Propofol from Swiss production

    https://www.bachem.com/fileadmin/user_upload/pdf/Press_Release/2020/Press_Release_Propofol_e.pdf

    PRESS RELEASE
    25 May 2020
    Share Share
    Bachem injects a million to accelerate its production of propofol
    Bachem injects a million to accelerate its production of propofol

    https://www.zonebourse.com/BACHEM-HOLDING-AG-408707/actualite/Bachem-injecte-un-million-pour-accelerer-sa-production-de-propofol-30666211/

    ZONEBOURSE
    24 May 2020
    Share Share
    Hikma responds to COVID-19 shortage with launch of Propofol Inj Emulsion, USP
    Hikma responds to COVID-19 shortage with launch of Propofol Inj Emulsion, USP

    https://www.prnewswire.com/news-releases/hikma-responds-to-covid-19-shortage-with-launch-of-propofol-injectable-emulsion-usp-301057188.html

    PR NEWSWIRE
    11 May 2020
    Share Share
    FDA Reports More Shortages of Drugs Used to Put COVID-19 Patients on Ventilators
    FDA Reports More Shortages of Drugs Used to Put COVID-19 Patients on Ventilators

    https://www.raps.org/news-and-articles/news-articles/2020/4/fda-reports-more-shortages-of-drugs-used-to-put-co

    Zachary Brennan RAPS
    14 Apr 2020
    Share Share
    Coronavirus demand causes shortages of anesthetics, painkillers
    Coronavirus demand causes shortages of anesthetics, painkillers

    https://www.fiercepharma.com/manufacturing/coronavirus-demand-causes-shortages-hospital-anesthetics-painkillers

    Kyle Blankenship FIERCE PHARMA
    14 Apr 2020
    Share Share
    Propofol Injectable Emulsion -Drug shortage
    Propofol Injectable Emulsion -Drug shortage

    https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Propofol+Injectable+Emulsion&st=c&tab=tabs-4&panels=0

    FDA
    10 Apr 2020
    Share Share
    Dr Reddy's launches injection for anesthesia and sedation in US market
    Dr Reddy's launches injection for anesthesia and sedation in US market

    https://www.business-standard.com/article/pti-stories/dr-reddy-s-launches-anesthetic-in-us-market-119012400430_1.html

    BUSINESS STANDARD
    24 Jan 2019
    Share Share
    Dr Reddys Labs ' Generic Propofol Receives Approval in US
    Dr Reddys Labs ' Generic Propofol Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205067

    FDA
    22 Nov 2018
    Share Share
    Anvisa Suspends 32 lots of Diprivan
    Anvisa Suspends 32 lots of Diprivan

    https://www.pharmacompass.com/pdf/news/anvisa-suspends-32-lots-of-diprivan-1520577378.pdf

    ANVISA
    08 Mar 2018
    Share Share
    Diprivan®(Propofol): Fresenius Kabi USA, LLC, v. BioQ Pharma Incorporated
    Diprivan®(Propofol): Fresenius Kabi USA, LLC, v. BioQ Pharma Incorporated

    https://www.pharmacompass.com/pdf/news/diprivanpropofol-fresenius-kabi-usa-llc-v-bioq-pharma-incorporated-1520249697.pdf

    PATENT LITIGATION
    02 Mar 2018
    Share Share
    Diprivan® (Propofol) : Fresenius Kabi USA v. Bioq Pharma
    Diprivan® (Propofol) : Fresenius Kabi USA v. Bioq Pharma

    https://www.pharmacompass.com/pdf/news/diprivan-propofol-fresenius-kabi-usa-v-bioq-pharma-1520832781.pdf

    PATENT LITIGATION
    01 Mar 2018
    Share Share
    Gathering: Medicines Diprivan and Depakote
    Gathering: Medicines Diprivan and Depakote

    https://www.pharmacompass.com/pdf/news/gathering-medicines-diprivan-and-depakote-1515654959.pdf

    FDA
    11 Jan 2018
    Share Share
    Pharmascience Inc. Recalls pms-PROPOFOL
    Pharmascience Inc. Recalls pms-PROPOFOL

    https://www.pharmacompass.com/pdf/news/pharmascience-inc-recalls-pms-propofol-1499402770.pdf

    HEALTH CANADA
    07 Jul 2017
    Share Share
    Pharmascience Inc. Recalls Propofol Due To Contamination By Foreign Particles
    Pharmascience Inc. Recalls Propofol Due To Contamination By Foreign Particles

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/62278r-eng.php

    HEALTH CANADA
    21 Feb 2017
    Share Share
    Hospira Inc., Ongoing Class I recall of Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30. because of Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
    Hospira Inc., Ongoing Class I recall of Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30. because of Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0389-2015&w=02252015&lang=eng

    FDA
    25 Feb 2015
    Share Share
    Hospira Inc., Ongoing Class II recall of Propofol Injectable Emulsion, 1%, 200 mg/20 mL, (10mg/mL), 20 mL, Single patient infusion vial, Contains Benzyl Alcohol, For I.V. Administration, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30 because of Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.
    Hospira Inc., Ongoing Class II recall of Propofol Injectable Emulsion, 1%, 200 mg/20 mL, (10mg/mL), 20 mL, Single patient infusion vial, Contains Benzyl Alcohol, For I.V. Administration, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30 because of Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0381-2015&w=02042015&lang=eng

    FDA
    04 Feb 2015
    Share Share
    Recall: PMS-Propofol
    Recall: PMS-Propofol

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/43615r-eng.php

    HEALTHY CANADIANS
    02 Feb 2015
    Share Share
    Claris Confirms Patent Challenge for Generic Propofol in US
    Claris Confirms Patent Challenge for Generic Propofol in US

    http://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/claris-confirms-patent-challenge-for-generic-propofol-in-us/articleshow/45620906.cms

    PRESS RELEASE THE ECONOMIC TIMES
    23 Dec 2014
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    bachem propofol

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Sigmak Lifesciences Propofol

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search